These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 33431171)

  • 1. Corrigendum to "Inactivated STAT5 pathway underlies a novel inhibitory role of EBF1 in chronic lymphocytic leukemia" [Exp. Cell Res. 398(1) 112371].
    Wang C; Li L; Li M; Shen X; Liu Y; Wang S
    Exp Cell Res; 2021 Mar; 400(1):112469. PubMed ID: 33431171
    [No Abstract]   [Full Text] [Related]  

  • 2. Resveratrol inhibits STAT5 activation through the induction of SHP-1 and SHP-2 tyrosine phosphatases in chronic myelogenous leukemia cells.
    Li Q; Zhang L; Ma L; Bai X; Li X; Zhao M; Sui T
    Anticancer Drugs; 2018 Aug; 29(7):646-651. PubMed ID: 29878900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.
    Welsh SJ; Churchman ML; Togni M; Mullighan CG; Hagman J
    Leukemia; 2018 Jan; 32(1):38-48. PubMed ID: 28555080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells.
    Gordiienko I; Shlapatska L; Kholodniuk VM; Kovalevska L; Ivanivskaya TS; Sidorenko SP
    Exp Oncol; 2017 Dec; 39(4):291-298. PubMed ID: 29284783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins.
    Gupta R; Li W; Yan XJ; Barrientos J; Kolitz JE; Allen SL; Rai K; Chiorazzi N; Mongini PKA
    J Immunol; 2019 May; 202(10):2924-2944. PubMed ID: 30988120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.
    Schwartz AM; Putlyaeva LV; Covich M; Klepikova AV; Akulich KA; Vorontsov IE; Korneev KV; Dmitriev SE; Polanovsky OL; Sidorenko SP; Kulakovskiy IV; Kuprash DV
    Biochim Biophys Acta; 2016 Oct; 1859(10):1259-68. PubMed ID: 27424222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma.
    Kim C; Baek SH; Um JY; Shim BS; Ahn KS
    BMC Nephrol; 2016 Feb; 17():19. PubMed ID: 26911335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous loss of B lineage transcription factors leads to pre-B leukemia in Ebf1
    Ramírez-Komo JA; Delaney MA; Straign D; Lukin K; Tsang M; Iritani BM; Hagman J
    Oncogenesis; 2017 Jul; 6(7):e355. PubMed ID: 28692033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
    Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
    Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum to "miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway" [Exp. Cell Res. 378 (2019) 66-75].
    Ran RZ; Chen J; Cui LJ; Lin XL; Fan MM; Cong ZZ; Zhang H; Tan WF; Zhang GQ; Zhang YJ
    Exp Cell Res; 2020 Oct; 395(2):112183. PubMed ID: 32854919
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "TSP1 ameliorates age-related macular degeneration by regulating the STAT3-iNOS signaling pathway" [Exp. Cell Res. 388 (2020) 111811].
    Li J; He J; Zhang X; Li J; Zhao P; Fei P
    Exp Cell Res; 2020 Oct; 395(2):112221. PubMed ID: 32800581
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Tissue inhibitor of metalloproteinase 1 suppresses growth and differentiation of osteoblasts and osteoclasts by targeting the AKT pathway" [Exp. Cell Res. 389 (2020) 111930-11940].
    Xi Y; Huang H; Zhao Z; Ma J; Chen Y
    Exp Cell Res; 2020 Sep; 394(1):112189. PubMed ID: 32800209
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Ossification of the posterior ligament is mediated by osterix via inhibition of the β-catenin signaling pathway" [Exp. Cell Res. 349 (2016) 53-59].
    Shi L; Cai G; Shi J; Guo Y; Chen D; Chen D; Yang H
    Exp Cell Res; 2017 Jan; 350(1):300. PubMed ID: 27939955
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "TWIST1 alleviates hypoxia-induced damage of trophoblast cells by inhibiting mitochondrial apoptosis pathway" [Exp. Cell Res. 385 (2) (2019 dec 15) 111687].
    Ma L; Zhang Z; Dong K; Ma Y
    Exp Cell Res; 2020 Feb; 387(1):111777. PubMed ID: 31883683
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia.
    Minieri V; De Dominici M; Porazzi P; Mariani SA; Spinelli O; Rambaldi A; Peterson LF; Porcu P; Nevalainen MT; Calabretta B
    Cancer Res; 2018 Oct; 78(20):5793-5807. PubMed ID: 30154155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of signal transducer and activator of transcription 5 and 5b expression in Epstein-Barr virus-positive patients with chronic lymphocytic leukemia.
    Diamantopoulos PT; Sofotasiou M; Georgoussi Z; Giannakopoulou N; Papadopoulou V; Galanopoulos A; Kontandreopoulou E; Zervakis P; Pallaki P; Kalala F; Kyrtsonis MC; Dimitrakopoulou A; Vassilakopoulos T; Angelopoulou M; Spanakis N; Viniou NA
    Cancer Med; 2016 Sep; 5(9):2240-8. PubMed ID: 27367207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2/ARE pathway through a Keap1-independent mechanism" [Exp. Cell Res. (2017) 292-302].
    Liao W; Fu Z; Zou Y; Wen D; Ma H; Zhou F; Chen Y; Zhang M; Zhang W
    Exp Cell Res; 2017 Dec; 361(1):199. PubMed ID: 29110908
    [No Abstract]   [Full Text] [Related]  

  • 18. A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells.
    Martín-Rodríguez P; Guerra B; Hueso-Falcón I; Aranda-Tavío H; Díaz-Chico J; Quintana J; Estévez F; Díaz-Chico B; Amesty A; Estévez-Braun A; Fernández-Pérez L
    Front Pharmacol; 2018; 9():1546. PubMed ID: 30687103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia.
    Gleixner KV; Schneeweiss M; Eisenwort G; Berger D; Herrmann H; Blatt K; Greiner G; Byrgazov K; Hoermann G; Konopleva M; Waliul I; Cumaraswamy AA; Gunning PT; Maeda H; Moriggl R; Deininger M; Lion T; Andreeff M; Valent P
    Haematologica; 2017 Sep; 102(9):1519-1529. PubMed ID: 28596283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT5 in B cell development and leukemia.
    Malin S; McManus S; Busslinger M
    Curr Opin Immunol; 2010 Apr; 22(2):168-76. PubMed ID: 20227268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.